Also, SCTR overexpression was associated with decreased overall (SCTRlow tumors: HR = 0.5; P = 0.004) and progression‐free (SCTRlow tumors: HR = 0.7; P = 0.05; Fig. 4E–H) survivals in CRC. Here, SCTR is linked to colorectal carcinoma.